Testing effectiveness (Phase 2)UnknownNCT04237987
What this trial is testing
Low-dose Interleukin-2 in Combination With Standard Therapy on Idiopathic Inflammatory Myopathy
Who this might be right for
Inflammatory Myopathy
Peking University People's Hospital 20